MITI.OQBMitesco, INC

10-Q: Mitesco Faces Going Concern Doubt Amid Q3 Losses

Sentiment:

Quarterly Report


Mitesco, Inc. reported a significant net loss in Q3 2025 and faces substantial doubt about its ability to continue as a going concern, despite new ventures in data centers and AI.

Capital raiseThe company's continuance is dependent on raising capital to sustain operations.On October 31, 2025, the company entered into a Senior Secured 10% Original Issue Discount Convertible Promissory Note (2025 Bridge Note) financing agreement for a potential total funding of $1 million, with an initial funding of $250,000 net proceeds.The 2025 Bridge Note is convertible into common stock at $0.15 per share, subject to adjustments, and is secured by subsidiaries' securities and a first priority senior security interest in all company assets.
Worse than expectedNet income for the three months ended September 30, 2025, was a loss of $3,202,971, a significant deterioration from a net income of $2,077,028 in the comparable prior year period.Cash and cash equivalents decreased to a critically low $321 as of September 30, 2025, from $3,402 at December 31, 2024, indicating worsening liquidity.Revenue for the three months ended September 30, 2025, decreased to $3,000 from $23,500 in the prior year period, indicating a decline in current operational performance.Operating expenses increased substantially, contributing to the larger operating loss, driven by new business unit establishment and software development costs.The company explicitly states 'substantial doubt about our ability to continue as a going concern,' which is a critical negative indicator.

Summary

  • Mitesco, Inc. reported a net loss of $3,202,971 for the three months ended September 30, 2025, a significant decline from a net income of $2,077,028 in the prior year period.
  • For the nine months ended September 30, 2025, net income decreased to $159,981 from $1,711,107 in the comparable period of 2024.
  • Revenue for the three months ended September 30, 2025, was $3,000, down from $23,500 in the prior year, attributed to shifting resources to new software projects.
  • Nine-month revenue increased to $38,700 from $29,500, primarily from the new Centcore, LLC data center services.
  • Operating expenses surged to $1,014,422 for the three months and $1,668,862 for the nine months ended September 30, 2025, largely due to establishing new subsidiaries and software development, including $812,149 in stock-based compensation for Q3 2025.
  • Cash and cash equivalents stood at a critically low $321 as of September 30, 2025, down from $3,402 at December 31, 2024.
  • Total current liabilities were $17,583,270, and total liabilities were $23,950,712 as of September 30, 2025.
  • The company has substantial doubt about its ability to continue as a going concern due to recurring losses and negative cash flows from operations, and the need for additional funding.
  • A debt restructuring in FY2024 converted over $25 million of obligations into restricted common stock and Series A Preferred Stock.
  • The company is developing an AI-based application called 'Robo Agent' for residential real estate sales, expected Q4 FY2025, and secured a contract for a sports/pickleball arena application, expected late FY2025.

Sentiment

Score: 2

Explanation: The company faces severe financial distress, including a going concern doubt, critically low cash, significant losses, and substantial liabilities. While new business ventures are underway, their revenue generation is minimal, and the company remains highly dependent on further capital raises, which often come with dilutive terms. The identified material weaknesses in internal controls further compound the negative sentiment.

Positives

  • Net cash used in operating activities improved for the nine months ended September 30, 2025, to $308,963, compared to $399,775 in the prior year.
  • Total liabilities decreased from $26,605,787 at December 31, 2024, to $23,950,712 at September 30, 2025, primarily due to debt restructuring and settlements.
  • The company successfully extinguished all FY2024 bridge notes through conversion into Series A Preferred shares.
  • New business units, Centcore, LLC (data center services) and Vero Technology Ventures, LLC (cloud computing/AI), have been formed and are generating some revenue.
  • Development of the 'Robo Agent' AI application and a new sports/pickleball arena application are underway, with an executive and contract programmers hired to accelerate development.

Negatives

  • The company reported a significant net loss of $3,202,971 for the three months ended September 30, 2025, a substantial deterioration from a net income in the prior year.
  • Cash and cash equivalents are critically low at $321 as of September 30, 2025, indicating severe liquidity issues.
  • Revenue from data center services decreased significantly in Q3 2025 ($3,000 vs. $23,500), as resources were shifted to software development.
  • Operating expenses increased substantially due to the establishment of new subsidiaries and software development, including high stock-based compensation.
  • The company has a large accumulated deficit of $(63,695,370) as of September 30, 2025.
  • Interest expense increased significantly to $1,137,355 for the nine months ended September 30, 2025, primarily due to Series A preferred shares accretion and interest on legal settlements.
  • A loss on legal settlement of $500,000 was recorded in Q3 2025, and a loss on revaluation of Series A Preferred shares of $387,638 was also recorded.
  • The Kishon Note was in default status at September 30, 2025, with principal and interest totaling $431,666 and $224,939, respectively, due.

Risks

  • Substantial doubt exists about the company's ability to continue as a going concern for one year due to recurring losses, negative cash flows from operations, and the need to secure additional funding.
  • The company's continuance is dependent on raising capital and generating sufficient revenues, for which no formal agreement exists as of the filing date.
  • Significant changes in the company's ownership may limit the future use of its existing net operating loss carryforwards (approximately $63.1 million Federal and $17.7 million State).
  • Material weaknesses in disclosure controls and procedures were identified, including a lack of segregation of duties and insufficient resources for timely SEC reporting.
  • The company is subject to significant risks and uncertainties related to its new business plan, including the successful development and market acceptance of its AI-based applications and data center services.
  • The Series A Preferred Stock has mandatory redemption features requiring repayment in cash or common stock, which could further dilute shareholders or strain cash resources.
  • The company faces ongoing legal proceedings and obligations related to the winding down of its former clinic business activities, with total settlement obligations of $3,322,834 as of September 30, 2025.

Future Outlook

The company is actively developing new AI-based applications, including 'Robo Agent' for residential real estate sales, expected to be available for initial users in Q4 FY2025. A new application for the sports and pickleball arena is also expected to be completed in late FY2025. The company anticipates continuing its strategy of using consultants to control costs rather than building a large internal employment force. Its ability to continue operations is dependent on raising additional capital and generating sufficient revenues.

Management Comments

  • "We shifted much of our limited resources to our new software projects during Q3 and as a result we saw a reduction in data center revenue."
  • "The increase [in operating expenses] is the result of the Companys focus on establishing the operations of its newly formed subsidiaries as well as development of a software platform..."
  • "Our Companys recurring losses from operations and negative cash flows from operations and our need to raise additional funding to finance our operations raise substantial doubt about our ability to continue as a going concern."
  • "It is anticipated that this approach [using consultants] will continue indefinitely as it does not desire to create the overhead associated with a large employment force."

Industry Context

Mitesco is undergoing a significant strategic pivot, moving away from its failed primary care healthcare clinic operations towards high-growth technology sectors: data center services, cloud computing, and artificial intelligence. This aligns with broader industry trends emphasizing digital transformation and AI integration. However, the company is in a very early stage of these new ventures, operating with minimal cash and substantial legacy liabilities, which places it at a significant disadvantage compared to established players in these capital-intensive and competitive industries.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorNANewly elected directorDuring the nine months ended September 30, 2025Issued 2,400 shares of Series X Preferred Stock for compensation in lieu of services.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Internal Control WeaknessesIdentified material weaknesses in disclosure controls and procedures, including lack of segregation of duties and insufficient resources for timely SEC reporting.As of September 30, 2025Adversely affects the company's ability to record, process, summarize, and report financial information accurately and timely. The company intends to take corrective action.

Legal Proceedings

  • Total legal settlement obligations related to the winding down of clinic business activities amount to $3,322,834 as of September 30, 2025.
  • A Summary Judgment was granted on December 4, 2023, for the Egan Clinic (Vikings) for $488,491, with a total settlement obligation of $577,222 including interest.
  • A stipulation for Judgment was filed on December 21, 2023, for the St. Paul Clinic (The Grove) for $415,266, with a total settlement obligation of $485,860 including interest.
  • A Confession of Judgment was executed on April 2, 2024, for the St. Louis Park Clinic (Excelsior & Grand) for $425,350, with a total settlement obligation of $483,151 including interest.
  • A settlement agreement was entered on October 22, 2022, for the Maple Grove Clinic (Arbor Lakes) for $219,576, with a total settlement obligation of $284,580 including interest.
  • Amounts owed for the Radiant Clinic (LMC Welton) were settled for approximately $530,000 as of April 10, 2024.
  • A Final Judgment was granted on November 14, 2023, for the Quincy Clinic (1776 Curtis) for $348,764. An additional judgment of $500,000 was provided on August 8, 2025, to settle a modification action, bringing the total settlement obligation to $936,463 including interest.
  • The company is currently in negotiations for amounts owed for the Eden Prairie Clinic (TP Elevate) and believes no further obligations exist for the Nordhaus Clinic and administrative office leases.

Related Party Transactions

  • Acquired the source code and business activities of AgingTopic, LLC on December 6, 2024, for a $5,000 cash payment and royalty payments up to $150,000, followed by a 2.5% commission. AgingTopic is controlled by Ms. Amy Lance, wife of Mack Leath (CEO).
  • Lindstrom Note 1 and Lindstrom Note 2 were issued to Jenny Lindstrom, former Chief Legal Officer. These notes, along with accrued interest, were settled on April 24, 2025, by issuing 75,000 shares of restricted common stock.
  • Issued 2,400 shares of Series X Preferred Stock to a newly elected director for compensation in lieu of services ($60,000 value) during the nine months ended September 30, 2025.
  • Issued 20,000 shares of Series X Preferred Stock to an institutional investor and consultant for compensation in lieu of services ($500,000 value) during the nine months ended September 30, 2025.

Stakeholder Impact

  • **Shareholders**: Significant dilution has occurred and is likely to continue due to ongoing capital raises and debt conversions into common stock. The substantial doubt about going concern and recurring losses pose a high risk to shareholder value.
  • **Creditors**: The company has undertaken significant debt restructuring and legal settlements to address past obligations, but some notes remain in default, and new secured convertible notes have been issued, indicating ongoing risk.
  • **Employees/Consultants**: The company relies heavily on consultants rather than a large employee base, which may offer flexibility but could impact long-term stability and talent retention if not managed effectively.
  • **Customers (Centcore/VTV)**: The company's financial instability and going concern doubt could raise concerns about its ability to reliably provide long-term data center and software services, potentially impacting customer acquisition and retention.

Next Steps

  • Continue development of the 'Robo Agent' AI application, with initial users expected in Q4 FY2025.
  • Complete the new application for the sports and pickleball arena in late FY2025.
  • Secure additional funding to sustain operations and execute the business plan.
  • Address material weaknesses in disclosure controls and procedures, including lack of segregation of duties and insufficient resources for timely SEC reporting.
  • Continue negotiations to settle remaining obligations related to former clinic operations.

Key Dates

DateDescription
2020-11-01Entered agreement to open Nordhaus Clinic in Minneapolis, Minnesota.
2021-05-24Entered agreement to open St. Louis Park Clinic (Excelsior & Grand) in Minnesota.
2021-06-08Entered agreement to open Eden Prairie Clinic (TP Elevate) in Minnesota.
2021-06-24Entered agreement to open an administrative office in St. Louis Park, Minnesota.
2021-08-31Entered agreement to open St. Paul Clinic (The Grove) in Minnesota.
2021-09-09Entered agreement to open Radiant Clinic (LMC Welton) in Denver, Colorado.
2021-09-28Entered agreement to open Quincy Clinic (1776 Curtis) in Denver, Colorado.
2021-10-08Entered agreement to open Maple Grove Clinic (Arbor Lakes) in Minnesota.
2021-10-14Entered agreement to open Egan Clinic (Vikings) in Minnesota.
2022-05-10Entered Securities Purchase Agreement with Kishon Investments, LLC for a promissory note and warrants.
2022-05-23Issued Finnegan Note 1 to Jessica Finnegan.
2022-05-26Issued Finnegan Note 2 to Jessica Finnegan and Lindstrom Note 1 to Jenny Lindstrom.
2022-08-04Issued Finnegan Note 3 to the Finnegans.
2022-10-22Entered settlement agreement with leaseholder for Maple Grove Clinic for $219,576.
2022-11-11Kishon Note entered default status.
2022-11-21Finnegan Note 1 entered default status.
2022-11-29Issued Lindstrom Note 2 to Jenny Lindstrom.
2022-12-01Finnegan Note 2 and Lindstrom Note 1 entered default status.
2023-07-12Received confirmation of payment plan arrangement from SBA for PPP loan.
2023-11-06Received termination notice from landlord for Nordhaus Clinic lease.
2023-11-14Final Judgment granted for Quincy Clinic in the amount of $348,764.
2023-12-04Summary Judgment granted for Egan Clinic in the amount of $488,491.
2023-12-15Entry of final judgment for Egan Clinic.
2023-12-21Stipulation for Judgment filed for St. Paul Clinic in the amount of $415,266.
2024-01-19Final entry of judgment by the Court for St. Paul Clinic.
2024-04-02Agreed to and executed a Confession of Judgment for St. Louis Park Clinic in the amount of $425,350.
2024-04-10Received fully executed and recorded judgment for St. Louis Park Clinic; settled amounts owed for Radiant Clinic for approximately $530,000.
2024-06-01Announced the formation of Centcore, LLC and Vero Technology Ventures, LLC.
2024-10-28Filed Certificate of Designation for Series A Preferred Stock with the Nevada Secretary of State.
2024-12-06Closed on the acquisition of AgingTopic, LLC.
2024-12-31Effective date for conversion of $580,132 of 2024 Bridge Notes into Series A Preferred shares.
2025-01-01Series A Preferred Stock redemptions began monthly.
2025-01-01Adopted ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures.
2025-04-24Entered Obligation Exchange Agreement with Finnegan and Lindstrom to settle notes and other obligations.
2025-05-06Entered short term note payable agreement with an investor for $25,000 cash proceeds.
2025-05-19Entered Senior Secured 5% Original Issue Discount Promissory Notes with three institutional investors for $75,000 gross proceeds.
2025-07-21Entered Senior Secured 5% Original Issue Discount Promissory Notes with two institutional investors for $100,000 gross proceeds.
2025-08-01Retained executive to begin development of Robo Agent product set.
2025-08-08Settled Quincy Clinic legal matter by providing an additional judgment of $500,000.
2025-09-01Received contract for development of a new application related to sports and pickleball arena.
2025-09-30End of the reporting period for this Form 10-Q.
2025-10-31Entered Senior Secured 10% Original Issue Discount Convertible Promissory Note (2025 Bridge Note) financing agreement for potential $1 million, with initial net proceeds of $250,000.
2025-11-13Date of filing of this Form 10-Q and date of common stock outstanding count.

Recommendation

strong sell

Mitesco, Inc. presents an extremely high-risk investment profile. The company explicitly states 'substantial doubt about our ability to continue as a going concern,' which is the most critical red flag for any investor. Its cash position is critically low ($321 at quarter-end, $55,000 post-financing), while liabilities remain substantial. Despite efforts to pivot into data centers and AI, these new ventures are nascent, generating minimal revenue, and the company continues to incur significant operating losses. The reliance on highly dilutive convertible debt for financing, coupled with identified material weaknesses in internal controls and ongoing legal obligations from past failed ventures, indicates severe operational and financial instability. The risk of total capital loss is exceptionally high, making it an unsuitable investment for all but the most speculative, risk-tolerant investors.

Keywords

Mitesco, 10-Q, Quarterly Report, Going Concern, Net Loss, Data Center Services, Cloud Computing, Artificial Intelligence, AI, Robo Agent, SEC Filing, Financial Reporting, Liquidity, Debt Restructuring, Preferred Stock, Legal Settlements, Internal Controls

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.